CNMD
CONMED Corporation NYSE Listed Jul 23, 1987$32.58
+1.46%
vs $32.11
Mkt Cap $1.0B
52w Low $32.11
2.0% of range
52w High $55.81
50d MA $36.34
200d MA $41.38
P/E (TTM)
21.6x
EV/EBITDA
10.2x
P/B
1.0x
Debt/Equity
0.8x
ROE
4.5%
P/FCF
6.7x
RSI (14)
39.30
ATR (14)
$1.63
Beta
0.99
50d MA
$36.34
200d MA
$41.38
Avg Volume
512.2K
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
11311 Concept Boulevard · Largo, FL 33773-4908 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | AMC | 0.82 | 0.89 | +8.5% | 35.96 | +3.0% | +1.9% | +0.4% | -2.5% | +2.1% | +1.9% | — |
| Jan 28, 2026 | AMC | 1.32 | 1.43 | +8.3% | 38.69 | +0.2% | -3.6% | +2.9% | +2.1% | -1.1% | +2.9% | — |
| Nov 5, 2025 | AMC | 1.05 | 1.08 | +2.9% | 44.44 | -3.2% | -0.5% | -0.5% | -0.0% | +1.7% | -2.6% | — |
| Jul 30, 2025 | AMC | 1.13 | 1.15 | +1.8% | 50.14 | +4.1% | +2.0% | +2.2% | +2.3% | +0.0% | -4.6% | — |
| Apr 30, 2025 | AMC | 0.81 | 0.95 | +17.3% | 49.11 | +12.0% | +16.5% | +0.9% | -1.2% | -1.9% | +0.2% | — |
| Feb 5, 2025 | AMC | 1.20 | 1.34 | +11.7% | 74.00 | -5.3% | -9.0% | -1.4% | +1.3% | -3.4% | -3.9% | — |
| Oct 30, 2024 | AMC | 0.99 | 1.05 | +6.1% | 65.26 | +0.0% | +4.6% | +3.2% | +0.1% | +5.0% | +2.2% | — |
| Jul 31, 2024 | AMC | 0.91 | 0.98 | +7.7% | 69.04 | -8.2% | -5.4% | +5.1% | -4.4% | -0.3% | +1.6% | — |
| Apr 24, 2024 | AMC | 0.74 | 0.79 | +6.8% | 70.01 | -9.5% | -11.6% | +6.3% | +2.2% | +1.1% | +0.5% | — |
| Jan 31, 2024 | AMC | 1.11 | 1.06 | -4.5% | 95.60 | -12.4% | -12.4% | -3.4% | +1.9% | +1.1% | +0.0% | — |
| Oct 25, 2023 | AMC | 0.83 | 0.90 | +8.4% | 91.68 | +3.3% | +2.9% | +0.6% | +2.7% | -0.1% | +1.3% | — |
| Jul 26, 2023 | AMC | 0.79 | 0.83 | +5.1% | 122.63 | +8.9% | -3.6% | +0.4% | +1.9% | -2.4% | -2.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $36.66 | $36.94 | +0.8% | +0.4% | -2.5% | +2.1% | +1.9% | +2.1% |
| Apr 30 | JP Morgan | Maintains | Neutral → Neutral | — | $35.96 | $37.04 | +3.0% | +1.9% | +0.4% | -2.5% | +2.1% | +1.9% |
| Mar 17 | Piper Sandler | Downgrade | Overweight → Neutral | — | $37.41 | $37.30 | -0.3% | -0.2% | -1.7% | +0.2% | -2.3% | +1.9% |
| Jan 29 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $38.69 | $38.77 | +0.2% | -3.6% | +2.9% | +2.1% | -1.1% | +2.9% |
| Jan 29 | Needham | Maintains | Hold → Hold | — | $38.69 | $38.77 | +0.2% | -3.6% | +2.9% | +2.1% | -1.1% | +2.9% |
| Dec 8 | BofA Securities | Maintains | Neutral → Neutral | — | $40.07 | $40.07 | +0.0% | +1.2% | -3.9% | +0.1% | +2.1% | +2.5% |
| Nov 6 | Piper Sandler | Maintains | Overweight → Overweight | — | $44.44 | $43.00 | -3.2% | -0.5% | -0.5% | -0.0% | +1.7% | -2.6% |
| Nov 6 | JP Morgan | Maintains | Neutral → Neutral | — | $44.44 | $43.00 | -3.2% | -0.5% | -0.5% | -0.0% | +1.7% | -2.6% |
| Nov 6 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $44.44 | $43.00 | -3.2% | -0.5% | -0.5% | -0.0% | +1.7% | -2.6% |
| Jul 31 | Piper Sandler | Maintains | Overweight → Overweight | — | $50.14 | $52.22 | +4.1% | +2.0% | +2.2% | +2.3% | +0.0% | -4.6% |
| Jun 12 | Needham | Downgrade | Buy → Hold | — | $56.95 | $55.39 | -2.7% | -3.5% | -2.6% | -0.3% | -2.1% | -0.3% |
| May 1 | Needham | Maintains | Buy → Buy | — | $49.11 | $55.00 | +12.0% | +16.5% | +0.9% | -1.2% | -1.9% | +0.2% |
| May 1 | JP Morgan | Maintains | Neutral → Neutral | — | $49.11 | $55.00 | +12.0% | +16.5% | +0.9% | -1.2% | -1.9% | +0.2% |
| May 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $49.11 | $55.00 | +12.0% | +16.5% | +0.9% | -1.2% | -1.9% | +0.2% |
| Apr 28 | Stifel | Downgrade | Buy → Hold | — | $50.71 | $50.01 | -1.4% | +0.3% | +0.6% | -4.0% | +16.5% | +0.9% |
| Feb 6 | Needham | Maintains | Buy → Buy | — | $74.00 | $70.11 | -5.3% | -9.0% | -1.4% | +1.3% | -3.4% | -3.9% |
| Feb 6 | JP Morgan | Downgrade | Overweight → Neutral | — | $74.00 | $70.11 | -5.3% | -9.0% | -1.4% | +1.3% | -3.4% | -3.9% |
| Feb 6 | Stifel | Maintains | Buy → Buy | — | $74.00 | $70.11 | -5.3% | -9.0% | -1.4% | +1.3% | -3.4% | -3.9% |
| Feb 6 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $74.00 | $70.11 | -5.3% | -9.0% | -1.4% | +1.3% | -3.4% | -3.9% |
| Oct 31 | Needham | Maintains | Buy → Buy | — | $65.26 | $65.26 | +0.0% | +4.6% | +3.2% | +0.1% | +5.0% | +2.2% |
| Oct 4 | Needham | Maintains | Buy → Buy | — | $66.56 | $68.33 | +2.7% | +0.0% | -3.8% | -0.1% | -1.6% | -1.9% |
| Aug 1 | Needham | Maintains | Buy → Buy | — | $69.04 | $63.40 | -8.2% | -5.4% | +5.1% | -4.4% | -0.3% | +1.6% |
| Aug 1 | Piper Sandler | Maintains | Overweight → Overweight | — | $69.04 | $63.40 | -8.2% | -5.4% | +5.1% | -4.4% | -0.3% | +1.6% |
| Aug 1 | Stifel | Maintains | Buy → Buy | — | $69.04 | $63.40 | -8.2% | -5.4% | +5.1% | -4.4% | -0.3% | +1.6% |
| Aug 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $69.04 | $63.40 | -8.2% | -5.4% | +5.1% | -4.4% | -0.3% | +1.6% |
| Jul 25 | Needham | Maintains | Buy → Buy | — | $71.60 | $71.74 | +0.2% | -1.4% | +0.6% | -1.3% | -0.8% | -0.7% |
| May 6 | Needham | Maintains | Buy → Buy | — | $71.76 | $72.08 | +0.4% | -1.4% | +1.3% | -3.1% | +1.4% | +1.2% |
| Apr 25 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $70.01 | $63.37 | -9.5% | -11.6% | +6.3% | +2.2% | +1.1% | +0.5% |
| Apr 25 | JP Morgan | Maintains | Overweight → Overweight | — | $70.01 | $63.37 | -9.5% | -11.6% | +6.3% | +2.2% | +1.1% | +0.5% |
| Apr 25 | Piper Sandler | Maintains | Overweight → Overweight | — | $70.01 | $63.37 | -9.5% | -11.6% | +6.3% | +2.2% | +1.1% | +0.5% |
| Apr 25 | Needham | Maintains | Buy → Buy | — | $70.01 | $63.37 | -9.5% | -11.6% | +6.3% | +2.2% | +1.1% | +0.5% |
| Feb 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $95.60 | $83.75 | -12.4% | -12.4% | -3.4% | +1.9% | +1.1% | +0.0% |
| Feb 1 | Piper Sandler | Maintains | Overweight → Overweight | — | $95.60 | $83.75 | -12.4% | -12.4% | -3.4% | +1.9% | +1.1% | +0.0% |
| Feb 1 | JP Morgan | Maintains | Overweight → Overweight | — | $95.60 | $83.75 | -12.4% | -12.4% | -3.4% | +1.9% | +1.1% | +0.0% |
| Feb 1 | Needham | Maintains | Buy → Buy | — | $95.60 | $83.75 | -12.4% | -12.4% | -3.4% | +1.9% | +1.1% | +0.0% |
| Oct 27 | Piper Sandler | Maintains | Overweight → Overweight | — | $94.38 | $94.38 | +0.0% | +0.6% | +2.7% | -0.1% | +1.3% | +1.5% |
| Oct 26 | Stifel | Maintains | Buy → Buy | — | $91.68 | $94.66 | +3.3% | +2.9% | +0.6% | +2.7% | -0.1% | +1.3% |
| Oct 26 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $91.68 | $94.66 | +3.3% | +2.9% | +0.6% | +2.7% | -0.1% | +1.3% |
| Oct 26 | Needham | Maintains | Buy → Buy | — | $91.68 | $94.66 | +3.3% | +2.9% | +0.6% | +2.7% | -0.1% | +1.3% |
| Jul 27 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $122.63 | $133.57 | +8.9% | -3.6% | +0.4% | +1.9% | -2.4% | -2.5% |
| Jul 27 | Needham | Maintains | Buy → Buy | — | $122.63 | $133.57 | +8.9% | -3.6% | +0.4% | +1.9% | -2.4% | -2.5% |
| Jul 27 | JP Morgan | Maintains | Overweight → Overweight | — | $122.63 | $133.57 | +8.9% | -3.6% | +0.4% | +1.9% | -2.4% | -2.5% |
| Jul 24 | Needham | Maintains | Buy → Buy | — | $122.19 | $122.01 | -0.1% | -0.5% | -1.2% | +2.1% | -3.6% | +0.4% |
| Jun 5 | Needham | Maintains | Buy → Buy | — | $126.81 | $125.69 | -0.9% | -0.9% | +1.1% | +0.9% | +2.8% | +0.6% |
| May 22 | CL King | Maintains | Buy → Buy | — | $118.96 | $119.08 | +0.1% | +1.3% | -1.5% | -2.5% | +1.4% | +0.8% |
| Apr 27 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $114.11 | $117.99 | +3.4% | +12.3% | -2.0% | +0.2% | -0.8% | +1.3% |
| Apr 27 | Piper Sandler | Maintains | Overweight → Overweight | — | $114.11 | $117.99 | +3.4% | +12.3% | -2.0% | +0.2% | -0.8% | +1.3% |
| Apr 27 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $114.11 | $117.99 | +3.4% | +12.3% | -2.0% | +0.2% | -0.8% | +1.3% |
| Apr 27 | Stifel | Maintains | Buy → Buy | — | $114.11 | $117.99 | +3.4% | +12.3% | -2.0% | +0.2% | -0.8% | +1.3% |
| Apr 27 | Needham | Maintains | Buy → Buy | — | $114.11 | $117.99 | +3.4% | +12.3% | -2.0% | +0.2% | -0.8% | +1.3% |
No insider trades available.
8-K · 5.02
!!! Very High
CONMED Corporation -- 8-K 5.02: Executive Change
CONMED Corporation appointed John E. Gallagher as Executive Vice President, strengthening its leadership team and potentially signaling strategic operational focus.
Jun 17
8-K · 1.01
!! High
CONMED Corporation -- 8-K 1.01: Material Agreement
Jun 4
8-K · 1.01
!! High
CONMED Corporation -- 8-K 1.01: Material Agreement
CONMED secured additional incremental senior secured delayed draw term loan commitments through a First Amendment to its credit agreement, expanding its borrowing capacity for future operational needs.
Jun 1
8-K · 5.02
!!! Very High
CONMED Corporation -- 8-K 5.02: Executive Change
May 20
8-K
CONMED Corporation -- 8-K Filing
CONMED Corporation reported Q1 2026 sales of $317.0 million, down 1.3% year-over-year, signaling modest revenue headwinds despite operational continuity.
Apr 29
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
CONMED's leadership transition on March 13, 2026 creates uncertainty about strategic direction and execution capability, potentially impacting near-term stock performance until new management's vision becomes clear.
Mar 13
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Portfolio Management Llc | 2,076,417 | $73M | New | Mar 2026 |
| 2 | Bank Of America Corp /de/ | 1,402,620 | $50M | Added | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 1,384,042 | $49M | New | Mar 2026 |
| 4 | Morgan Stanley | 909,698 | $37M | Added | Dec 2025 |
| 5 | Sei Investments Co | 1,004,715 | $36M | Added | Mar 2026 |
| 6 | Cooke & Bieler Lp | 987,783 | $35M | Added | Mar 2026 |
| 7 | Capital Research Global Investors | 925,448 | $33M | — | Mar 2026 |
| 8 | Two Sigma Investments, Lp | 782,540 | $28M | Added | Mar 2026 |
| 9 | Allspring Global Investments Holdings, Llc | 582,733 | $21M | Added | Mar 2026 |
| 10 | Arrowstreet Capital, Limited Partnership | 419,092 | $15M | Added | Mar 2026 |
| 11 | Northern Trust Corp | 334,353 | $12M | Added | Mar 2026 |
| 12 | Jane Street Group, Llc | 276,858 | $11M | Added | Dec 2025 |
| 13 | Tributary Capital Management, Llc | 268,896 | $11M | New | Dec 2025 |
| 14 | Neuberger Berman Group Llc | 306,933 | $11M | Added | Mar 2026 |
| 15 | Bank Of New York Mellon Corp | 289,234 | $10M | Added | Mar 2026 |
| 16 | Glenmede Trust Co Na | 275,888 | $10M | New | Mar 2026 |
| 17 | Citadel Advisors Llc | 246,930 | $9M | Reduced | Mar 2026 |
| 18 | Principal Financial Group Inc | 184,778 | $8M | Added | Dec 2025 |
| 19 | Marshall Wace, Llp | 170,756 | $6M | Reduced | Mar 2026 |
| 20 | Invesco Ltd. | 166,640 | $6M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$1.01B
Enterprise Value
$1.81B
P/E (TTM)
21.58x
Forward P/E
7.48x
PEG Ratio
-0.41x
P/B
0.98x
P/S
0.74x
P/FCF
6.73x
EV/EBITDA
10.25x
Shares Out
31.1M
Financials (TTM)
Revenue
$1.37B
Net Income
$47.1M
EBITDA
$176.5M
Free Cash Flow
$150.9M
Op Cash Flow
$170.7M
EPS Basic
$1.52
EPS Diluted
$1.51
EPS Forward
$4.36
Gross Margin
54.6%
Op Margin
7.5%
Net Margin
3.4%
Balance Sheet
Total Assets
$2.33B
Total Liab.
$1.29B
Total Equity
$1.03B
Cash
$40.8M
LT Debt
$834.2M
Book Value/Sh
$33.29
Debt/Equity
0.81x
Current Ratio
2.14
Quick Ratio
1.01
Returns & Growth
ROE
4.5%
ROA
2.0%
ROIC
3.4%
Rev Growth YoY
+5.2%
EPS Growth YoY
-64.6%
Price Returns
2W
-1.8%
1M
-2.6%
3M
-22.4%
6M
-17.8%
12M
-37.1%
Technicals
52W High
$55.81
52W Low
$32.11
50d MA
$36.34
200d MA
$41.38
RSI (14)
39.30
ATR (14)
$1.63
Beta
0.99
Avg Volume
512K
Dividends
Div Rate
$0.80
Div Yield
2.2%
Frequency
4
Ex-Div Date
Sep 15, 2025
Analyst Price Targets
Consensus
$78.00
High
$95.00
Low
$61.00
Median
$78.00
Data updated apr 25, 2026 2:14am
· Source: financialmodelingprep.com